Trim41 is required to regulate chromosome axis protein dynamics and meiosis in male mice

PLoS Genet. 2022 Jun 1;18(6):e1010241. doi: 10.1371/journal.pgen.1010241. eCollection 2022 Jun.

Abstract

Meiosis is a hallmark event in germ cell development that accompanies sequential events executed by numerous molecules. Therefore, characterization of these factors is one of the best strategies to clarify the mechanism of meiosis. Here, we report tripartite motif-containing 41 (TRIM41), a ubiquitin ligase E3, as an essential factor for proper meiotic progression and fertility in male mice. Trim41 knockout (KO) spermatocytes exhibited synaptonemal complex protein 3 (SYCP3) overloading, especially on the X chromosome. Furthermore, mutant mice lacking the RING domain of TRIM41, required for the ubiquitin ligase E3 activity, phenocopied Trim41 KO mice. We then examined the behavior of mutant TRIM41 (ΔRING-TRIM41) and found that ΔRING-TRIM41 accumulated on the chromosome axes with overloaded SYCP3. This result suggested that TRIM41 exerts its function on the chromosome axes. Our study revealed that Trim41 is essential for preventing SYCP3 overloading, suggesting a TRIM41-mediated mechanism for regulating chromosome axis protein dynamics during male meiotic progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Male
  • Meiosis / genetics
  • Mice
  • Mice, Knockout
  • Nuclear Proteins* / genetics
  • Nuclear Proteins* / metabolism
  • Spermatocytes / metabolism
  • Synaptonemal Complex* / genetics
  • Synaptonemal Complex* / metabolism
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • Cell Cycle Proteins
  • Nuclear Proteins
  • Trim41 protein, mouse
  • Ubiquitin-Protein Ligases

Grants and funding

This work was supported by: the Japan Society for the Promotion of Science (JSPS) KAKENHI grants (JP19J21619 to S.O., JP19H05758 to T.H., JP18K14612 and JP20H03172 to T.N., 19H05743 to KI, and JP19H05750 and 21H04753 to M.I.); Takeda Science Foundation Grants to T.N. and M.I.; The Nakajima Foundation to T.N.; and the Bill & Melinda Gates Foundation (INV-001902 to M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.